silymarine

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• acne [Insufficient Evidence]
• acral erythema, chemo-induced [Insufficient Evidence]
• acute kidney injury [Insufficient Evidence]
• alcoholic liver disease [Insufficient Evidence]
• allergic rhinitis [Insufficient Evidence]
• Alzheimer disease [Insufficient Evidence]
• atrial fibrillation prevention [Insufficient Evidence]
• beta-thalassemia [Insufficient Evidence]
• BPH [Insufficient Evidence]
• COVID-19 [Insufficient Evidence]
• critical illness (trauma) [Insufficient Evidence]
• diabetes mellitus [Possibly Effective]
• diabetic nephropathy [Insufficient Evidence]
• dyslipidemia [Insufficient Evidence]
• dyspepsia [Insufficient Evidence]
• endometriosis [Insufficient Evidence]
• gambling disorder [Insufficient Evidence]
• hepatic cirrhosis [Insufficient Evidence]
• hepatitis [Insufficient Evidence]
• hepatitis B [Insufficient Evidence]
• hepatitis C [Insufficient Evidence]
• hepatotoxicity, chemo-induced [Insufficient Evidence]
• hepatotoxicity, toxin-induced [Insufficient Evidence]
• hyperlipoproteinemia [Insufficient Evidence]
• hypoxic liver injury [Insufficient Evidence]
• infertility in patients of childbearing potential [Insufficient Evidence]
• lactation promotion [Insufficient Evidence]
• melasma [Insufficient Evidence]
• menopausal symptoms [Insufficient Evidence]
• metabolic dysfunction-associated steatohepatitis [Insufficient Evidence]
• metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• multiple sclerosis [Insufficient Evidence]
• mushroom toxicity (Amanita phalloides) [Insufficient Evidence]
• nephropathy prophylaxis, contrast-induced [Insufficient Evidence]
• nephrotoxicity, chemo-induced [Insufficient Evidence]
• obesity [Insufficient Evidence]
• obsessive-compulsive disorder [Insufficient Evidence]
• Parkinson disease [Insufficient Evidence]
• peripheral neuropathy, chemo-induced [Insufficient Evidence]
• postpartum complications [Insufficient Evidence]
• prostate CA [Insufficient Evidence]
• radiation dermatitis [Insufficient Evidence]
• radiation mucositis [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• trichotillomania [Insufficient Evidence]
• ulcerative colitis [Insufficient Evidence]
• vitiligo [Insufficient Evidence]